Delivery Order SPE2DB20D3101-SPE2DB23FRLE7

Award Date 5/10/23
Potential Completion Date 5/11/23
Potential Value $5.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,418.77, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Cefixime 200 mg/5 ml suspension in 50 ml containers. This is a Firm Fixed Price delivery order contract with a completion date of May 2, 2023. The contract has no set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award is for the delivery of CEFIXIME 200MG/5ML 1S medical supplies to the Medical Supply Chain, a division of the Defense Logistics Agency (DLA). The contract, valued at $12,336.42, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of June 20, 2023. The contract is not designated with a set-aside...
This federal contract award, valued at $9,030.85, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, valued at up to $999,999,999.00 through November 2026. The contract is for the delivery of CEFIXIME 200MG/5ML 1S, a pharmaceutical product, to support military healthcare programs. The contract does...
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $3,159.96 Firm Fixed Price Delivery Order provides Cefixime 400 mg capsules to the DLA. This award is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,541.09, is for the delivery of 4,563,004,539 units of the anti-infective medication Cefixime 400 mg capsules. The contract has an ultimate completion date of December 6, 2023 and is a firm fixed-price delivery order. This award is not designated as a set-aside contract. AmerisourceBergen Drug...
This federal contract award, valued at $15,150.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Cefixime 200 mg/5 ml suspension in 75 ml bottles. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare programs, particularly within military and...
This federal contract award is for the delivery of CEFIXIME 400 MG CAPSULE 50S to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price pricing type, with a ceiling value of $6,303.74 and an ultimate completion date of September 21, 2023. The contract is not designated with any set-aside...
This federal contract award, with an ID of SPE2DX15D6028|SPE2DX23FWQEX, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,880.72 firm-fixed-price delivery order is for the supply of 4560916056 - CEFIXIME 200MG/5ML 1S, a medical commodity. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,287.47, is for the delivery of 4560878924 Cefixime 400 mg capsules. The award is a Delivery Order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a division of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The $11,519.69 firm fixed price delivery order is for the supply of CEFIXIME 400 MG CAPSULE 50S, with a completion date of February 14, 2024. This award does not have a set-aside designation. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FRLE7
    Delivery Order

This federal contract award, valued at $5,276.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4560896490 - CEFIXIME 200 MG/5 ML SUSP 50ML, a pharmaceutical product. The contract has a completion date of May 11, 2023 and is a Firm Fixed Price Delivery Order.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract award reviewed was not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.

Generated 5/9/25, 9:56 AM